Empirical Finance LLC Raises Holdings in Kenvue Inc. (NYSE:KVUE)

Empirical Finance LLC boosted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 3.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,127 shares of the company’s stock after acquiring an additional 786 shares during the quarter. Empirical Finance LLC’s holdings in Kenvue were worth $558,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Leo Wealth LLC boosted its position in Kenvue by 0.3% during the third quarter. Leo Wealth LLC now owns 151,611 shares of the company’s stock worth $3,507,000 after purchasing an additional 481 shares in the last quarter. Alerus Financial NA raised its stake in shares of Kenvue by 0.3% during the 3rd quarter. Alerus Financial NA now owns 191,345 shares of the company’s stock worth $4,426,000 after buying an additional 491 shares during the period. Kiley Juergens Wealth Management LLC lifted its position in shares of Kenvue by 1.9% during the 4th quarter. Kiley Juergens Wealth Management LLC now owns 27,110 shares of the company’s stock valued at $579,000 after buying an additional 500 shares in the last quarter. Wolff Wiese Magana LLC grew its stake in Kenvue by 0.7% in the 3rd quarter. Wolff Wiese Magana LLC now owns 76,999 shares of the company’s stock valued at $1,781,000 after acquiring an additional 501 shares during the period. Finally, LS Investment Advisors LLC increased its holdings in Kenvue by 1.1% in the 3rd quarter. LS Investment Advisors LLC now owns 51,745 shares of the company’s stock worth $1,197,000 after acquiring an additional 570 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. UBS Group decreased their price objective on shares of Kenvue from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday. Piper Sandler raised shares of Kenvue from a “neutral” rating to an “overweight” rating and raised their price target for the company from $21.00 to $26.00 in a research note on Monday, January 6th. Canaccord Genuity Group cut their price objective on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research note on Friday. Royal Bank of Canada reissued a “sector perform” rating and set a $24.00 target price on shares of Kenvue in a report on Monday, February 3rd. Finally, Barclays lowered their price target on Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $23.00.

Kenvue Trading Up 2.1 %

Shares of NYSE KVUE opened at $20.60 on Tuesday. The stock has a fifty day simple moving average of $21.54 and a 200-day simple moving average of $22.00. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $39.49 billion, a PE ratio of 38.86, a PEG ratio of 2.16 and a beta of 1.45.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities analysts forecast that Kenvue Inc. will post 1.05 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th will be issued a dividend of $0.205 per share. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.98%. Kenvue’s dividend payout ratio (DPR) is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.